Holen Sie sich die Stockscreener-App
0.5789
5.31%
0.0292
Handel nachbörslich:
.57
-0.0089
-1.54%
Finanzdaten der Seres Therapeutics Inc-Aktie (MCRB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
0.064 | 0.31 | 126.47 | -0.522 |
Operating Expenses
|
0.01%
39.59
|
39.59 | 47.72 | 76.95 | 70.05 |
| Operating Income/Loss |
0.15%
-39.59
|
-39.53 | -47.41 | 49.52 | -70.57 |
| Nonoperating Income/Loss |
68.23%
-0.547
|
-1.722 | -0.441 | -2.972 | -0.606 |
| Income/Loss From Continuing Operations Before Tax |
62,808%
-40.13
|
0.064 | 0.31 | 46.55 | -71.17 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
2.70%
-40.13
|
-41.25 | -47.85 | 46.55 | -71.17 |
|
Net Income/Loss
|
2.70%
-40.13
|
-41.25 | -47.85 | 46.55 | -71.17 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
20,605%
146.10
|
0.7056 | 128.29 | 127.71 | 125.86 |
| Diluted Average Shares |
20,605%
146.10
|
0.7056 | 128.29 | 129.84 | 125.86 |
| Basic Earnings Per Share |
15.63%
-0.27
|
-0.32 | -0.37 | 0.36 | -0.57 |
| Diluted Earnings Per Share |
15.63%
-0.27
|
-0.32 | -0.37 | 0.36 | -0.57 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):